JP2001514013A5 - - Google Patents

Download PDF

Info

Publication number
JP2001514013A5
JP2001514013A5 JP2000507836A JP2000507836A JP2001514013A5 JP 2001514013 A5 JP2001514013 A5 JP 2001514013A5 JP 2000507836 A JP2000507836 A JP 2000507836A JP 2000507836 A JP2000507836 A JP 2000507836A JP 2001514013 A5 JP2001514013 A5 JP 2001514013A5
Authority
JP
Japan
Prior art keywords
ltc
synthase gene
polymorphism
single nucleotide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000507836A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001514013A (ja
Filing date
Publication date
Priority claimed from GBGB9717766.1A external-priority patent/GB9717766D0/en
Application filed filed Critical
Publication of JP2001514013A publication Critical patent/JP2001514013A/ja
Publication of JP2001514013A5 publication Critical patent/JP2001514013A5/ja
Pending legal-status Critical Current

Links

JP2000507836A 1997-08-22 1998-08-18 Ｌｔｃ４シンターゼ多型の分析方法および診断への利用 Pending JP2001514013A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9717766.1 1997-08-22
GBGB9717766.1A GB9717766D0 (en) 1997-08-22 1997-08-22 Methods
PCT/GB1998/002468 WO1999010529A1 (en) 1997-08-22 1998-08-18 Methods for analyzing ltc4 synthase polymorphisms and diagnostic use

Publications (2)

Publication Number Publication Date
JP2001514013A JP2001514013A (ja) 2001-09-11
JP2001514013A5 true JP2001514013A5 (https=) 2006-01-05

Family

ID=10817852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000507836A Pending JP2001514013A (ja) 1997-08-22 1998-08-18 Ｌｔｃ４シンターゼ多型の分析方法および診断への利用

Country Status (6)

Country Link
US (2) US6316196B1 (https=)
EP (1) EP1007738A1 (https=)
JP (1) JP2001514013A (https=)
AU (1) AU8814798A (https=)
GB (2) GB9717766D0 (https=)
WO (1) WO1999010529A1 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881571B1 (en) 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2798392B1 (fr) * 1999-09-13 2005-07-15 Exonhit Therapeutics Sa Marqueurs genetiques de la toxicite, preparation et utilisations
AU3793701A (en) * 1999-11-29 2001-06-04 Orchid Biosciences, Inc. Methods of identifying optimal drug combinations and compositions thereof
WO2001079560A2 (en) * 2000-04-17 2001-10-25 Glaxo Group Limited Medicine response assay in respiratory disease
CN1329012A (zh) * 2000-06-21 2002-01-02 上海博德基因开发有限公司 一种新的多肽——烟酰胺腺嘌呤脱氧二核苷酸依赖性白三烯b412－羟基脱氢酶36和编码这种多肽的多核甘酸
US20050009023A1 (en) * 2001-07-03 2005-01-13 Neil Richtand Glucocorticoid-induced receptor and methods of use
JP2005505272A (ja) * 2001-09-17 2005-02-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 双極性障害と関連する脳で発現されるｃａｐ−２遺伝子およびタンパク質
WO2004067779A2 (en) * 2003-01-30 2004-08-12 Applera Corporation Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
US20050019795A1 (en) * 2003-04-24 2005-01-27 Aventis Pharma Deutschland Gmbh Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders
WO2005056837A2 (en) * 2003-11-26 2005-06-23 Applera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
WO2006045318A2 (en) * 2004-10-27 2006-05-04 Aarhus Universitet Diagnosis and treatment of immune-related diseases
US20070207455A1 (en) * 2005-11-17 2007-09-06 Third Wave Technologies, Inc. Compositions and methods for detecting an HCV-1 subtype
EP2027284A2 (en) * 2006-05-18 2009-02-25 Sanofi-Aventis Use of adamts4 gene and protein polymorphisms
AU2007264371A1 (en) * 2006-06-30 2008-01-03 Clifford L. Librach Method of detecting preeclampsia
EP2639317B1 (en) * 2006-09-11 2015-03-04 Celera Corporation Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
WO2008039941A2 (en) 2006-09-27 2008-04-03 The Government Of The Usa As Represented By The Secretary Of The Dpt. Of Health And Human Services Scgb3a2 as a growth factor and anti-apoptotic agent
US7811765B2 (en) * 2006-10-12 2010-10-12 Children's Hospital & Research Center At Oakland Methods and compositions for determining predisposition to inflammation-mediated cardiovascular disease
US20080248470A1 (en) * 2007-04-04 2008-10-09 Sungkyunkwan University Foundation For Corporate Collaboration Genetic screening for predicting antidepressant drug response based on the monoamine transporter gene polymorphism combination
US9079961B2 (en) * 2007-05-25 2015-07-14 Japanese Red Cross Society GPIIIa gene
AU2008312556A1 (en) * 2007-10-19 2009-04-23 Marshfield Clinic Method for administering anticoagulation therapy
WO2009061734A1 (en) * 2007-11-05 2009-05-14 The Government Of The United States Of America As Represented By The Secretary Of The Deparment Of Health And Human Services Identification of subjects likely to benefit from statin therapy
US7947451B2 (en) * 2007-11-30 2011-05-24 Celera Corporation Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
WO2009097418A2 (en) * 2008-01-29 2009-08-06 The Johns Hopkins University Sr-bi as a predictor of elevated high density lipoprotein and cardiovascular disease
ES2744797T3 (es) * 2008-02-29 2020-02-26 Univ Oxford Innovation Ltd Procedimiento de determinación de una dosis adecuada de estatina
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
DE102008064509B4 (de) * 2008-12-22 2017-06-08 Robert Bosch Gesellschaft mbH für medizinische Forschung Verfahren zur Bestimmung der Prädisposition für Morbus Crohn
CA2706021C (en) * 2009-05-28 2018-10-16 Institut De Cardiologie De Montreal Genetic predictors of international normalized ratio (inr) fluctuation with warfarin therapy
WO2011068610A1 (en) * 2009-12-01 2011-06-09 Quest Diagnostics Investments Incorporated Methods for detecting risk of myelodysplastic syndrome by genotypic analysis
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US20140087960A1 (en) * 2010-12-14 2014-03-27 Johanna M. Seddon Markers Related to Age-Related Macular Degeneration and Uses Therefor
US9534256B2 (en) * 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
EP2766728B1 (en) 2011-10-13 2017-09-06 Boston Heart Diagnostics Compositions and methods for treating and preventing coronary heart disease
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
US10098893B2 (en) * 2013-10-03 2018-10-16 Northwestern University Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457
US11761043B2 (en) 2014-05-29 2023-09-19 Geneticure Inc. Machine assay and analysis for selecting antihypertensive drugs
US10590485B2 (en) * 2014-05-29 2020-03-17 Geneticure Llc Therapeutic regimen for hypertension
WO2016073298A1 (en) * 2014-11-04 2016-05-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Parp genomic variants conferring resistance and sensitization to chemotherapy under inhibition
EP3220810A4 (en) 2014-11-17 2018-05-16 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment
WO2022261351A1 (en) * 2021-06-09 2022-12-15 The University Of North Carolina At Chapel Hill Improved methods to diagnose head and neck cancer and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018178A1 (en) * 1992-03-13 1993-09-16 The Children's Hospital Of Philadelphia DIAGNOSIS OF β-THALASSEMIA USING A MULTIPLEX AMPLIFICATION REFRACTORY MUTATION SYSTEM
AU4304293A (en) 1992-06-15 1994-01-04 Merck Frosst Canada Inc. Leukotriene c4 synthase
WO1995032280A1 (en) * 1994-05-20 1995-11-30 Brigham And Women's Hospital Dna encoding human leukotriene c4 synthase, polypeptides, and uses therefor
US5952210A (en) * 1994-06-03 1999-09-14 G. D. Searle & Company Nucleic acids and expression vectors encoding human leukotiene C4 synthase
CA2253823A1 (en) 1996-05-06 1997-11-13 Brigham And Women's Hospital 5-lipoxygenase gene polymorphisms and their use in classifying patients

Similar Documents

Publication Publication Date Title
JP2001514013A5 (https=)
EP0679190B1 (en) Method for generating single-stranded dna molecules
Day et al. Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction
JP2003500071A5 (https=)
AU2002348612A1 (en) Hybridization portion control oligonucleotide and it's uses
JP2002272489A5 (https=)
PT1527199E (pt) Processos para detectar ácidos nucleicos metilados de forma anormal em amostras biológicas heterogéneas
JP2004511201A5 (https=)
WO2001077384A3 (de) DETEKTION VON SNPs UND CYTOSIN-METHYLIERUNGEN
NZ522406A (en) Single copy genomic hybridization probes and method of generating same
Bürger et al. Different mechanisms and recurrence risks of imprinting defects in Angelman syndrome
JP2001521765A5 (https=)
JP2005508642A5 (ja) 試験サンプル中のＭｙｃｏｐｌａｓｍａ ｐｎｅｕｍｏｎｉａｅの存在を決定するための組成物、方法およびキット
Macaya et al. A synonymous mutation in TCOF1 causes Treacher Collins syndrome due to mis‐splicing of a constitutive exon
Bensen et al. Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster
JP4073471B2 (ja) 塩基変異分析用プライマー
EP1589115A2 (en) Polymorphisms of the human organic anion transporting polypeptide-C (OATP-C)
WO2002006523A3 (en) Method for detecting pre-disposition to hepatotoxicity
Greber-Platzer et al. Evidence against the current hypothesis of “gene dosage effects” of trisomy 21: ets-2, encoded on chromosome 21” is not overexpressed in hearts of patients with Down syndrome
JPH06133800A (ja) 増幅方法
WO2008143367A1 (en) Haplotyping method by multiplex amplification
JP2004261017A5 (https=)
Yu et al. ADLAPH: A molecular haplotyping method based on allele-discriminating long-range PCR
JP2004504028A5 (https=)
JPH09107970A (ja) Ｃ型肝炎ウイルス由来核酸、該核酸を用いたウイルスの検出方法